ConductScience.org, home
NPC1L1: NPC1 like intracellular cholesterol transporter 1
API referenceFor AI assistants

Gene · 29881

Papers2,068

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 2,068

Download this page as JSON
TitleJournalYearPMIDFound bySource
Perinatal bisphenol AP exposure induces multigenerational cardiometabolic dysfunction via dysregulation of cholesterol synthesis and transport.Environ Pollut202642772435PubTator, text miningPubMed
Thermosonication-induced structural remodeling of faba bean protein: Improved functionality, digestibility, and cholesterol metabolism regulation for cardiovascular health.Ultrason Sonochem202642721809PubTator, text miningPubMed
Increased LDL-C reduction with ezetimibe in ketogenic diet-induced hypercholesterolemia.Lipids Health Dis202642661192PubTator, text miningPubMed
Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis.J Endocrinol Invest202642645756PubTator, text miningPubMed
Site-specific cholesterol depletion therapy for gastric cancer.J Lipid Res202642612977PubTator, text miningPubMed
[Research advance on regulation of SREBP pathway by TCM in prevention and treatment of hyperlipidemia].Zhongguo Zhong Yao Za Zhi202642543324PubTator, text miningPubMed
Lipids and Lipid-Lowering Drugs With Risk of Intervertebral Disc Degeneration: A Mendelian Randomization Study.Genet Res (Camb)202642528182PubTator, text miningPubMed
Site-specific cholesterol depletion therapy for gastric cancer.bioRxiv202642523283PubTator, text miningPubMed
Marigold flavonoids coordinate emulsion stabilization, epithelial transport and gut microbiota modulation to enhance intestinal lutein absorption.J Sci Food Agric202642517507PubTator, text miningPubMed
Corrigendum to "Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway" [Phytomedicine, 125 (2024), 155299].Phytomedicine202642509114PubTator, text miningPubMed
Precision nutrition in Asian populations: a Multi-omics review of mechanisms, biomarkers, and implementation pathways.J Nutr Sci202642459212PubTator, text miningPubMed
Shared molecular dysregulation across neuropsychiatric disorders reveals candidate therapeutic targets.Adv Protein Chem Struct Biol202642448418PubTator, text miningPubMed
Genetically Proxied Inhibition of Cholesterol-Lowering Drug Targets and Survival in HPV-Positive and Non-HPV-Driven Head and Neck Cancer: A Multicentre MR Study.Cancer Epidemiol Biomarkers Prev202642390334PubTator, text miningPubMed
Corrigendum to "Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway" [Phytomedicine, 125 (2024), 155299].Phytomedicine202642385434PubTator, text miningPubMed
Niemann-Pick C1-Like 1 in Cholesterol Absorption and Homeostasis: Mechanisms, Regulation, and Emerging Phytochemical Inhibitors.Curr Issues Mol Biol202642353596PubTator, text miningPubMed
Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation-Based Strategies.Lipids202642312550PubTator, text miningPubMed
The role of lipid-lowering drugs in urologic and male reproductive cancers: a Mendelian randomization study.Transl Androl Urol202642293830PubTator, text miningPubMed
Rare variants in cholesterol transporter genes in patients with lipid metabolism disorders.Vavilovskii Zhurnal Genet Selektsii202642253452PubTator, text miningPubMed
Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study.Medicine (Baltimore)202642216396PubTator, text miningPubMed
Targeting Hyperlipidemia: Investigating the Regulatory Roles of NPC1L1 and SREBP-2 and the Therapeutic Potential of Bioactive Compounds.Cardiovasc Hematol Disord Drug Targets202642136228PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/29881/papers

API referenceFor AI assistants